Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
July 31, 2026 55.48%
April 30, 2026 54.01%
January 31, 2026 52.84%
October 31, 2025 52.50%
July 31, 2025 51.78%
April 30, 2025 52.88%
January 31, 2025 53.24%
October 31, 2024 54.38%
July 31, 2024 55.01%
April 30, 2024 54.42%
January 31, 2024 55.07%
October 31, 2023 54.86%
July 31, 2023 54.25%
April 30, 2023 53.99%
January 31, 2023 55.47%
October 31, 2022 51.70%
July 31, 2022 55.36%
April 30, 2022 53.89%
January 31, 2022 54.54%
October 31, 2021 54.04%
July 31, 2021 54.04%
April 30, 2021 53.97%
January 31, 2021 54.65%
October 31, 2020 53.41%
July 31, 2020 52.97%
Date Value
April 30, 2020 52.75%
January 31, 2020 53.28%
October 31, 2019 53.62%
July 31, 2019 54.32%
April 30, 2019 53.96%
January 31, 2019 54.60%
October 31, 2018 54.48%
July 31, 2018 54.86%
April 30, 2018 53.73%
January 31, 2018 55.57%
October 31, 2017 54.58%
July 31, 2017 53.41%
April 30, 2017 53.63%
January 31, 2017 53.70%
October 31, 2016 52.93%
July 31, 2016 52.11%
April 30, 2016 51.91%
January 31, 2016 52.14%
October 31, 2015 51.69%
July 31, 2015 50.30%
April 30, 2015 49.12%
January 31, 2015 49.61%
October 31, 2014 45.93%
July 31, 2014 49.85%
April 30, 2014 51.94%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 40.94%
Danaher Corp. 57.64%
Illumina, Inc. 66.49%
Bio-Rad Laboratories, Inc. 53.12%
Revvity, Inc. 50.26%

Gross Profit Margin (Quarterly) Related Metrics